SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-23-004026
Filing Date
2023-06-21
Accepted
2023-06-21 06:10:14
Documents
13
Period of Report
2023-06-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_062023.htm   iXBRL 8-K 22354
2 EXHIBIT 99.1 exh_991.htm EX-99.1 11309
  Complete submission text file 0001171843-23-004026.txt   210496

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abus-20230621.xsd EX-101.SCH 2974
4 XBRL LABEL FILE abus-20230621_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE abus-20230621_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_062023_htm.xml XML 3489
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 231027366
SIC: 2834 Pharmaceutical Preparations